Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blackstone Minerals | OTC Markets | Basic Materials | Metals & Mining | 474.5% | US$23.85M | -3x | -0.06 | US$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gorilla Tech | NASDAQ | Technology | Software & IT Services | 265.9% | US$544.34M | 3.2x | 0.23 | US$26.93 | -8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.3% Upside | Upgrade to Pro+ | |
Dominari Holdings | NASDAQ | Healthcare | Biotechnology & Medical Research | 231.2% | US$45.03M | -1.2x | -0.15 | US$4.41 | -10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medbright AI Investments | OTC Markets | Financial | Investment Banking & Investment Services | 200.4% | US$4.49M | -1.4x | -0.02 | US$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Artemis Resources | OTC Markets | Basic Materials | Metals & Mining | 164% | US$9.82M | -0.6x | -0.05 | US$0.010 | 676.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ibio | NASDAQ | Healthcare | Biotechnology & Medical Research | 116.2% | US$43.95M | -1.8x | -0.04 | US$4.52 | -7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.6% Downside | Upgrade to Pro+ | |
Wins Finance Holdings | OTC Markets | Financial | Investment Banking & Investment Services | 108.7% | US$12.43M | -43.6x | US$0.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Axim Biotech | OTC Markets | Healthcare | Biotechnology & Medical Research | 79.4% | US$3.13M | -0.6x | -0.01 | US$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ATIF Holdings | NASDAQ | Industrials | Professional & Commercial Services | 62.2% | US$16.62M | -2.5x | -0.29 | US$0.99 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DBV Technologies | NASDAQ | Healthcare | Pharmaceuticals | 51.2% | US$103.15M | -0.9x | -1.56 | US$4.72 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cavitation Techs Inc | OTC Markets | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | 50.8% | US$6.77M | 5.9x | 0.04 | US$0.02 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
EverQuote A | NASDAQ | Technology | Software & IT Services | 50.1% | US$951.33M | 28.8x | 0.19 | US$26.46 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.8% Upside | Upgrade to Pro+ | |
BeiGene ADS | NASDAQ | Healthcare | Biotechnology & Medical Research | 47% | US$28.40B | -44.4x | -1.57 | US$261.38 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.7% Upside | Upgrade to Pro+ | |
TriSalus Life Sciences | NASDAQ | Healthcare | Biotechnology & Medical Research | 35.6% | US$151.83M | -2.1x | -0.03 | US$5.10 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jericho Oil | OTC Markets | Energy | Oil & Gas | 34.8% | US$25.46M | -3x | 0.08 | US$0.12 | 17.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SpringWorks | NASDAQ | Healthcare | Biotechnology & Medical Research | 34.5% | US$3.69B | -14.1x | -0.46 | US$49.04 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.2% Upside | Upgrade to Pro+ | |
Pinetree Capital | OTC Markets | Financial | Investment Banking & Investment Services | 32.9% | US$95.01M | 4.1x | 0.01 | US$10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Protagonist Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 32.1% | US$3.32B | 12.1x | 0.03 | US$54.52 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29% Upside | Upgrade to Pro+ | |
Cannabis Bioscience International Holdings | OTC Markets | Healthcare | Biotechnology & Medical Research | 27.3% | US$7.35M | -13.5x | -0.31 | US$0.0007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CorMedix | NASDAQ | Healthcare | Pharmaceuticals | 26% | US$634.08M | -13.2x | -2.38 | US$10.43 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LandBridge Co LLC | NYSE | Energy | Oil & Gas | 22.8% | US$5.63B | 310.5x | US$72.35 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.5% Upside | Upgrade to Pro+ | ||
BioRestorative Therapies | NASDAQ | Healthcare | Biotechnology & Medical Research | 21.2% | US$11.83M | -1.2x | -0.06 | US$1.67 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
51Talk Online Education DRC | NYSE | Academic & Educational Services | Miscellaneous Educational Service Providers | 19.1% | US$122.85M | -8.3x | -2.71 | US$23.95 | 12.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Harbors | NYSE | Real Estate | Residential & Commercial REITs | 19% | US$1.44B | 5.8x | 0.02 | US$13.81 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.9% Downside | Upgrade to Pro+ | |
Two | NYSE | Real Estate | Real Estate Operations | 19% | US$950.87M | 3.8x | 0.02 | US$9 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BridgeBio Pharma | NASDAQ | Healthcare | Pharmaceuticals | 19% | US$6.17B | -11.2x | -0.43 | US$32.19 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Global Net Lease | NYSE | Real Estate | Residential & Commercial REITs | 17.6% | US$1.84B | -10.5x | -0.19 | US$8.02 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Himalaya Shipping | NYSE | Industrials | Freight & Logistics Services | 17.1% | US$254.70M | 11.5x | 0.01 | US$5.70 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quinsam Capital | OTC Markets | Financial | Investment Banking & Investment Services | 16.7% | US$3.18M | -12.6x | -0.17 | US$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mesabi Trust | NYSE | Basic Materials | Metals & Mining | 16% | US$358.18M | 3.9x | 0.01 | US$26.91 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dynex Capital | NYSE | Real Estate | Residential & Commercial REITs | 15.8% | US$1.31B | 9.6x | 0.02 | US$14.42 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.1% Downside | Upgrade to Pro+ | |
Sprott Physical Gold and Silver Trust | NYSE | Financial | Collective Investments | 13.3% | US$5.70B | 3.8x | US$28.02 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Annaly Capital Management | NYSE | Real Estate | Residential & Commercial REITs | 13.3% | US$12.68B | 13.5x | 0.1 | US$21.92 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.9% Downside | Upgrade to Pro+ | |
Anterix | NASDAQ | Technology | Telecommunications Services | 13.1% | US$724.70M | -24x | 0.08 | US$38.98 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
InterDigital | NASDAQ | Technology | Communications & Networking | 10.6% | US$5.62B | 15.5x | 0.27 | US$219.05 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
AGNC Invest | NASDAQ | Real Estate | Residential & Commercial REITs | 10.1% | US$9.36B | 11.1x | 0.01 | US$10.39 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.5% Upside | Upgrade to Pro+ | |
NXU | NASDAQ | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | 10% | US$6.07M | -0.1x | -0 | US$0.24 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fennec Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 9.4% | US$180.98M | -2,210x | -25.49 | US$6.57 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascentage Pharma | NASDAQ | 9.3% | US$1.66B | -0.53 | US$19.69 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||||
Cobalt Blue | OTC Markets | Basic Materials | Metals & Mining | 9.1% | US$19.45M | -0.7x | 0 | US$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tetragon | OTC Markets | Financial | Collective Investments | 7.9% | US$1.23B | 3.6x | US$14.62 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Arcutis | NASDAQ | Healthcare | Biotechnology & Medical Research | 7.7% | US$1.87B | -13.9x | -0.18 | US$15.87 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
Orchid Island Capital | NYSE | Real Estate | Residential & Commercial REITs | 7.5% | US$782.73M | 14.7x | 0.12 | US$8.39 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
AI Artificial Intelligence Ventures | OTC Markets | Financial | Investment Banking & Investment Services | 7.4% | US$9.07M | -14.5x | -0.2 | US$0.31 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Krystal Biotech | NASDAQ | Healthcare | Biotechnology & Medical Research | 7% | US$5.46B | 61.1x | 0.09 | US$188.50 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15% Upside | Upgrade to Pro+ | |
Hims Hers Health | NYSE | Healthcare | Healthcare Providers & Services | 6% | US$7.01B | 54x | 0.1 | US$31.49 | -9.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.2% Upside | Upgrade to Pro+ | |
MGM China Holdings | OTC Markets | Consumer Cyclicals | Hotels & Entertainment Services | 6% | US$5.41B | 9.4x | 0.03 | US$16.15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invesco Mortgage Pref | NYSE | Real Estate | Residential & Commercial REITs | 5.5% | US$539.52M | 13.6x | 0.09 | US$23.77 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rigel | NASDAQ | Healthcare | Pharmaceuticals | 5.2% | US$364.94M | 20.7x | 0.12 | US$20.33 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.2% Upside | Upgrade to Pro+ | |
Annaly Capital Management Pref | NYSE | Real Estate | Residential & Commercial REITs | 5% | US$12.68B | 13.5x | 0.1 | US$25.98 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |